Nektar to cut over 500 jobs following cancer drug failure
- ByReuters-
(Reuters) - Nektar Therapeutics (NASDAQ:NKTR) said on Monday it would lay off about 70% of its workforce, or more than 500 employees, after stopping the development of its key...